Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 1/2020

Ausgabe 1/2020

Inhaltsverzeichnis ( 24 Artikel )

21.03.2020 | Preclinical study | Ausgabe 1/2020 Open Access

The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer

Rokaya El Ansari, Lutfi Alfarsi, Madeleine L. Craze, Brendah K. Masisi, Ian O. Ellis, Emad A. Rakha, Andrew R. Green

30.03.2020 | Preclinical study | Ausgabe 1/2020

The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer

Jan J. Jobsen, Henk Struikmans, Job van der Palen, Ester Siemerink

02.04.2020 | Preclinical study | Ausgabe 1/2020

Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival

Rita A. Mukhtar, Gregor Krings, Yunn-Yi Chen, Matina E. Mamounas, Kelly Fahrner-Scott, Jasmine Wong, Michael Alvarado, Cheryl Ewing, Laura J. Esserman, Hope Rugo

02.04.2020 | Preclinical study | Ausgabe 1/2020

LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer

Li Pan, Xiang Chen, Shengling Fu, Wenying Yu, Chenglong Li, Tiffany Wang, Hui-Wen Lo, Jiayuh Lin

17.03.2020 | Clinical trial | Ausgabe 1/2020

Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes

M. J. Hassett, H. Li, H. J. Burstein, R. S. Punglia

17.03.2020 | Clinical trial | Ausgabe 1/2020

Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner

Giovanna Panzironi, Giuliana Moffa, Francesca Galati, Flaminia Marzocca, Veronica Rizzo, Federica Pediconi

21.03.2020 | Clinical trial | Ausgabe 1/2020

Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial

Alessandra Gennari, Flavia Foca, Rita Zamarchi, Andrea Rocca, Dino Amadori, Andrea De Censi, Alessandra Bologna, Luigi Cavanna, Lorenzo Gianni, Laura Scaltriti, Elisabetta Rossi, Antonella Facchinetti, Veronica Martini, Paolo Bruzzi, Oriana Nanni

25.03.2020 | Clinical trial | Ausgabe 1/2020

Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients

Antônio Luiz Frasson, Martina Lichtenfels, Alessandra Anton Borba de Souza, Betina Vollbrecht, Ana Beatriz Falcone, Mônica Adriana Rodriguez Martinez Frasson, Fernanda Barbosa

31.03.2020 | Clinical trial | Ausgabe 1/2020 Open Access

Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience

Ingeborg J. H. Vriens, Elena M. ter Welle-Butalid, Maaike de Boer, Christine E. M. de Die-Smulders, Josien G. Derhaag, Sandra M. E. Geurts, Irene E. G. van Hellemond, Ernest J. T. Luiten, M. Wouter Dercksen, Bea M. D. Lemaire, Els R. M. van Haaren, Birgit E. P. J. Vriens, Agnes J. van de Wouw, Anne-marie M. G. H. van Riel, Sandra L. E. Janssen-Engelen, Marlène H. W. van de Poel, Ester E. M. Schepers-van der Sterren, Ron J. T. van Golde, Vivianne C. G. Tjan-Heijnen

31.03.2020 | Clinical trial | Ausgabe 1/2020 Open Access

Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer

Yvonne Brandberg, Hemming Johansson, Mats Hellström, Michael Gnant, Volker Möbus, Richard Greil, Theodoros Foukakis, Jonas Bergh, the Swedish Breast Cancer Group, the Austrian Breast, Colorectal Cancer Study Group, the German Breast Cancer Group

02.04.2020 | Clinical trial | Ausgabe 1/2020 Open Access

Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer

Hannelore Denys, Corina L. Martinez-Mena, Marc T. Martens, Randal G. D’Hondt, Marie-Pascale L. Graas, Ella Evron, Georgeta Fried, Noa E. Ben-Baruch, Christof Vulsteke, Mona M. Van Steenberghe

02.04.2020 | Clinical trial | Ausgabe 1/2020

Metformin is distributed to tumor tissue in breast cancer patients in vivo: A 11C-metformin PET/CT study

Elias Immanuel Ordell Sundelin, Nidal al-Suliman, Pernille Vahl, Mikkel Vendelbo, Ole Lajord Munk, Steen Jakobsen, Steen Bønløkke Pedersen, Jørgen Frøkiær, Lars C. Gormsen, Niels Jessen

19.03.2020 | Epidemiology | Ausgabe 1/2020

Behavior of metastatic breast cancer according to subtype

Margot Van Mechelen, Anke Van Herck, Kevin Punie, Ines Nevelsteen, Ann Smeets, Patrick Neven, Caroline Weltens, Sileny Han, Adriaan Vanderstichele, Giuseppe Floris, Jean-Pierre Lobelle, Hans Wildiers

29.03.2020 | Epidemiology | Ausgabe 1/2020

Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma

Wei Liu, Wei Li, Ziyao Li, Lei Shi, Peng Zhao, Zihong Guo, Jiawei Tian, Zhenzhen Wang

31.03.2020 | Epidemiology | Ausgabe 1/2020

Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?

Whitney L. Do, Karen Conneely, Sheryl Gabram-Mendola, Uma Krishnamurti, Olivia D’Angelo, Jasmine Miller-Kleinhenz, Keerthi Gogineni, Mylin Torres, Lauren E. McCullough

31.03.2020 | Epidemiology | Ausgabe 1/2020

Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers

Kristen S. Purrington, David Gorski, Michael S. Simon, Theresa A. Hastert, Seongho Kim, Rayna Rosati, Ann G. Schwartz, Manohar Ratnam

31.03.2020 | Epidemiology | Ausgabe 1/2020

Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes

Inna Y. Gong, Andrew T. Yan, Craig C. Earle, Maureen E. Trudeau, Andrea Eisen, Kelvin K. W. Chan

01.04.2020 | Epidemiology | Ausgabe 1/2020

The association between soy isoflavone intake and menopausal symptoms after breast cancer diagnosis: a prospective longitudinal cohort study on Chinese breast cancer patients

Yuan-Yuan Lei, Suzanne C. Ho, Ashley Cheng, Carol Kwok, Ka Li Cheung, Yi-Qian He, Roselle Lee, Winnie Yeo

03.04.2020 | Epidemiology | Ausgabe 1/2020

Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome

Anh N. Le, Joanna Harton, Heena Desai, Jacquelyn Powers, Kristin Zelley, Angela R. Bradbury, Katherine L. Nathanson, Payal D. Shah, Abigail Doucette, Gary M. Freedman, Peter Gabriel, Susan M. Domchek, Suzanne P. MacFarland, Kara N. Maxwell

03.04.2020 | Epidemiology | Ausgabe 1/2020

Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer

Takehiro Hirai, Asuka Nemoto, Yoshinori Ito, Masaaki Matsuura

03.04.2020 | Epidemiology | Ausgabe 1/2020

Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors

Maria Alice Franzoi, Caroline Vandeputte, Daniel Eiger, Rafael Caparica, Mariana Brandão, Claudia De Angelis, Alain Hendlisz, Ahmad Awada, Martine Piccart, Evandro de Azambuja

05.04.2020 | Epidemiology | Ausgabe 1/2020

A maintained absolute lymphocyte count predicts the overall survival benefit from eribulin therapy, including eribulin re-administration, in HER2-negative advanced breast cancer patients: a single-institutional experience

J. Watanabe, M. Saito, Y. Horimoto, S. Nakamoto

31.03.2020 | Brief Report | Ausgabe 1/2020

Breast implant-associated anaplastic large cell lymphoma: emotional impact and guidelines for psychological support

Serena Oliveri, Giulia Ongaro, Ilaria Durosini, Giuseppe Curigliano, Gabriella Pravettoni

31.03.2020 | Brief Report | Ausgabe 1/2020

HER2 borderline is a negative prognostic factor for primary malignant breast cancer

Atanu Bhattacharjee, Jacinth Rajendra, Rajesh Dikshit, Shilpee Dutt

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.